We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSFE icon
2301
Paysafe
PSFE
$362M
$835K ﹤0.01%
52,882
+697
+1% +$9.75K
EQBK icon
2302
Equity Bancshares
EQBK
$1.04B
$834K ﹤0.01%
24,265
+703
+3% +$23K
OFIX icon
2303
Orthofix Medical
OFIX
$418M
$832K ﹤0.01%
57,304
-419
-0.7% -$5.79K
CART icon
2304
Maplebear
CART
$11.7B
$832K ﹤0.01%
22,299
+4,597
+26% +$135K
ORIC icon
2305
Oric Pharmaceuticals
ORIC
$1.39B
$829K ﹤0.01%
60,300
+2,396
+4% +$28.5K
FIP icon
2306
FTAI Infrastructure
FIP
$527M
$829K ﹤0.01%
131,940
+4,499
+4% +$20.9K
MSBI icon
2307
Midland States Bancorp
MSBI
$692M
$827K ﹤0.01%
32,924
+921
+3% +$23.2K
TBPH icon
2308
Theravance Biopharma
TBPH
$876M
$827K ﹤0.01%
92,179
-4,611
-5% -$42.7K
TVTX icon
2309
Travere Therapeutics
TVTX
$5.89B
$825K ﹤0.01%
107,015
-1,221
-1% -$10.3K
CDLX icon
2310
Cardlytics
CDLX
$21.7M
$824K ﹤0.01%
5,685
+205
+4% +$17.3K
HTBK
2311
DELISTED
Heritage Commerce
HTBK
$818K ﹤0.01%
95,380
+2,561
+3% +$22.4K
SSRM icon
2312
SSR Mining
SSRM
$6.41B
$818K ﹤0.01%
183,367
-41,435
-18% -$289K
IRON icon
2313
Disc Medicine
IRON
$2.99B
$818K ﹤0.01%
13,132
+486
+4% +$31.5K
OLO
2314
DELISTED
Olo Inc
OLO
$817K ﹤0.01%
148,781
+2,954
+2% +$16.1K
UVE icon
2315
Universal Insurance Holdings
UVE
$1.22B
$816K ﹤0.01%
40,163
+991
+3% +$17.8K
VPG icon
2316
Vishay Precision Group
VPG
$888M
$815K ﹤0.01%
23,066
-57
-0.2% -$1.89K
KE
2317
Kimball Electronics
KE
$613M
$815K ﹤0.01%
37,632
-443
-1% -$10K
NRC icon
2318
NRC Health Common Stock
NRC
$451M
$814K ﹤0.01%
20,561
+457
+2% +$18.1K
NVRO
2319
DELISTED
NEVRO CORP.
NVRO
$811K ﹤0.01%
56,159
+1,229
+2% +$20.3K
SRI icon
2320
Stoneridge
SRI
$204M
$809K ﹤0.01%
43,898
-462
-1% -$8.2K
BSAC icon
2321
Banco Santander Chile
BSAC
$16.6B
$809K ﹤0.01%
40,792
+810
+2% +$15.5K
SSP icon
2322
E.W. Scripps
SSP
$326M
$808K ﹤0.01%
205,574
+5,613
+3% +$33.6K
NICE icon
2323
Nice
NICE
$5.99B
$805K ﹤0.01%
3,089
+409
+15% +$92.8K
TMCI icon
2324
Treace Medical Concepts
TMCI
$308M
$803K ﹤0.01%
61,568
+1,208
+2% +$16.1K
MRSN
2325
DELISTED
Mersana Therapeutics
MRSN
$802K ﹤0.01%
7,158
+755
+12% +$75.1K

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.